Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artificial Intelligence in Vaccine and Drug Design
Sunil Thomas, Ann Abraham, Jeremy Baldwin, et al.
Methods in molecular biology (2021), pp. 131-146
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
Arshpreet Kaur, Jeremy Baldwin, Deshkanwar Brar, et al.
Current Opinion in Chemical Biology (2022) Vol. 70, pp. 102172-102172
Open Access | Times Cited: 112
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 66
Development and use of machine learning algorithms in vaccine target selection
Barbara Bravi
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
mRNA therapeutics: New vaccination and beyond
Huanhuan Wei, Liangliang Zheng, Zefeng Wang
Fundamental Research (2023) Vol. 3, Iss. 5, pp. 749-759
Open Access | Times Cited: 36
Artificial intelligence in accelerating vaccine development - current and future perspectives
Rahul Kaushik, Ravi Kant, Myron Christodoulides
Frontiers in Bacteriology (2023) Vol. 2
Open Access | Times Cited: 27
Artificial intelligence in Immuno-genetics
Raed Farzan
Bioinformation (2024) Vol. 20, Iss. 1, pp. 29-35
Open Access | Times Cited: 13
Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
Lei Li, Yoshikazu Honda‐Okubo, Jeremy Baldwin, et al.
Vaccine (2022) Vol. 40, Iss. 23, pp. 3182-3192
Open Access | Times Cited: 37
Transforming Aquaculture through Vaccination: A Review on Recent Developments and Milestones
Iosif Tammas, Konstantina Bitchava, Athanasios Ι. Gelasakis
Vaccines (2024) Vol. 12, Iss. 7, pp. 732-732
Open Access | Times Cited: 8
Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines
Wei Zhang, Xiaoli Zheng, Paolo Coghi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine
Nikolai Petrovsky
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Next-Generation Vaccine Development with Nanomaterials: Recent Advances, Possibilities, and Challenges
Shamitha Shetty, Pablo Cordero Alvarado, Deleah Pettie, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 273-306
Closed Access | Times Cited: 7
Data-Driven Analytics Leveraging Artificial Intelligence in the Era of COVID-19: An Insightful Review of Recent Developments
Abdul Majeed, Seong Oun Hwang
Symmetry (2021) Vol. 14, Iss. 1, pp. 16-16
Open Access | Times Cited: 37
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates
Ranajit Pal, Maria Grazia Ferrari, Yoshikazu Honda‐Okubo, et al.
Vaccine (2024) Vol. 42, Iss. 5, pp. 1122-1135
Closed Access | Times Cited: 5
Artificial intelligence-inspired comprehensive framework for Covid-19 outbreak control
Munish Bhatia, Ankush Manocha, Tariq Ahamed Ahanger, et al.
Artificial Intelligence in Medicine (2022) Vol. 127, pp. 102288-102288
Open Access | Times Cited: 19
Sharing Data With Shared Benefits: Artificial Intelligence Perspective
Mohammad Tajabadi, Linus Grabenhenrich, Adèle H. Ribeiro, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e47540-e47540
Open Access | Times Cited: 11
Combating COVID-19 Crisis using Artificial Intelligence (AI) Based Approach: Systematic Review
Kavya Singh, Navjeet Kaur, Ashish A. Prabhu
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 8, pp. 737-753
Closed Access | Times Cited: 4
Unveiling the ghost: machine learning’s impact on the landscape of virology
Sebastian Bowyer, David J. Allen, Nicholas Furnham
Journal of General Virology (2025) Vol. 106, Iss. 1
Closed Access
The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy
Jingjing Song, Yujun Zhang, Chulin Zhou, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112037-112037
Closed Access | Times Cited: 3
Vaccinology in the artificial intelligence era
Gianmarco Gasperini, Norman W. Baylor, Steve Black, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 794
Closed Access
Integrating artificial intelligence into public health education and healthcare: insights from the COVID-19 and monkeypox crises for future pandemic readiness
Mustapha Abdelouahed, Dana Yateem, Chadi Amzil, et al.
Frontiers in Education (2025) Vol. 10
Open Access
Considerations for mRNA Product Development, Regulation and Deployment Across the Lifecycle
John Howard Skerritt
Vaccines (2025) Vol. 13, Iss. 5, pp. 473-473
Open Access
Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants
Yoshikazu Honda‐Okubo, Richard A. Bowen, Mckinzee Barker, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7116-7128
Closed Access | Times Cited: 8
Viral informatics: bioinformatics-based solution for managing viral infections
Sanjay Kumar, Geethu S. Kumar, Subhrangsu Sundar Maitra, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 14
Leveraging Artificial Intelligence and Machine Learning in Predicting and Managing Pandemics: Lessons Learnt and Future Implications in the Healthcare Sector
Steward Mudenda, Shafiq Mohamed
Scholars Academic Journal of Biosciences (2024) Vol. 12, Iss. 01, pp. 16-21
Open Access | Times Cited: 2
A Predictive Model of Vaccine Reactogenicity Using Data from an In Vitro Human Innate Immunity Assay System
Robert H. Pullen, Emily Sassano, Pankaj Agrawal, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 5, pp. 904-916
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top